Feds add fraud charges to the multitude of accusations made against former MiMedx execs
You can add federal charges of accounting fraud to the steadily growing mound of accusations faced by former top executives of MiMedx Group.
The Justice Department has indicted ex-CEO Parker Petit and ex-President William Taylor on fraud charges related to overstating revenue and misleading investors of the tissue repair company. And the SEC followed up with a civil suit outlining a claim that Petit, Taylor and former CFO Michael Senken engaged in accounting fraud over a 4-year period stretching from 2013 to 2017.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 82,000+ biopharma pros reading Endpoints daily — and it's free.